EUCTR2006-002237-20-DE进行中（未招募）不适用
Pilot trial studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients with Type II Diabetes and Insulin Resistance undergoing elective PTCA
Takeda Pharma GmbH0 个研究点开始时间: 2006年6月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients with stable coronary artery disease with planned Stent-PCI
- •2. Patients with type II diabetes and / or IRIS score > 50
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •PCI within less than 15 days after acreening visit, use of systemic corticosteroids, Anamnestic history of hypersensitivity to the study drugs or to drugs with similar chemical structures, history of esvere multiple allergies, have had more than one unexplained episode of severe hypoglycaemia within 6 months prior to screening visit, progressive fatal disease, pre-treatment with PPar gamma agonists within the 3 months prior to screening, if insulin therapy applicable: initiation of insulin treament within the last 3 months, a history of significant cardiovascular (NYHA stage II-IV), respiratory, gastrointestinal, hepatic (ALAT > 2.5 times normal ref. range), renal (creatinine >1.2 in women and >1.5 mg/dl in men and/or GFR < 45), neurological, psychiatric and or haematological disease as judged by the investigator
研究者
相似试验
已完成
不适用
A study to investigate the effect of pioglitazone on whole body and myocardial glucose uptake and myocardial blood flow/coronary vasodilator reserve in patients with familial combined hyperlipidaemiaISRCTN78563659Takeda Europe R and D Centre (UK)26
进行中（未招募）
不适用
Ensayo clínico piloto de tratamiento con Pioglitazona+Flutamida+Metformina a Dosis Bajas versus Etinil-Estradiol + Acetato de Ciproterona como control, en Adolescentes con Hiperandrogenismo Ovárico e Hiperinsulinismo: Efectos sobre Parámetros de Inflamación Crónica, Diabetes Tipo 2 y Riesgo CardiovacularHiperandrogenismo ovárico asociado a hiperinsulinismo.EUCTR2009-012226-37-ESHOSPITAL SANT JOAN DE DÉ
已完成
2 期
Study of efficacy and side effects of Pioglitazone in the treatment of psoriasisPsoriasis vulgarisPsoriasis.IRCT138903013862N2Research Council of Mashhad University of Medical Sciences26
已完成
2 期
Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)Autism Spectrum DisordersNCT01205282Evdokia Anagnostou28
已完成
2 期
Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusDiabetes MellitusNCT00762736Takeda704